JABA RECORDATI,S.A. secures contract for Antineoplastic and immunomodulating agents - 2023/0491 - LEUPRORRELINA [45 MG; PO E SOLV P/ SOL INJ; SERINGA]

Portugal, Aug. 19 -- Portugal based JABA RECORDATI,S.A. has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491 - LEUPRORRELINA [45 MG; PO E SOLV P/ SOL INJ; SERINGA]. The value of the contract is worth 21516550 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....